GLP-1 agonists linked to reduced dementia risk in type 2 diabetes patients
People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to…
Empowering Your Journey to a Healthier You
Wellness Accelerator
